TC-067533

CAS No. 1093070-10-0

TC-067533( —— )

Catalog No. M28798 CAS No. 1093070-10-0

TC-067533 is a Papain-like protease inhibitor with an IC50 of 8.7 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 100 Get Quote
5MG 142 Get Quote
10MG 221 Get Quote
25MG 417 Get Quote
50MG 610 Get Quote
100MG 871 Get Quote
500MG 1737 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TC-067533
  • Note
    Research use only, not for human use.
  • Brief Description
    TC-067533 is a Papain-like protease inhibitor with an IC50 of 8.7 μM.
  • Description
    TC-067533 is a Papain-like protease inhibitor with an IC50 of 8.7 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VHL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1093070-10-0
  • Formula Weight
    289.37
  • Molecular Formula
    C20H19NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](c1cc2ccccc2cc1)NC(c1c(C)cccc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zengerle M, et al. Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4. ACS Chemical Biology (2015), 10(8), 1770-1777.
molnova catalog
related products
  • Anisindione

    Anisindione is a synthetic anticoagulant and an indanedione derivative.?It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K–mediated gamma-carboxylation of precursor proteins.

  • Tusamitamab

    Tusamitamab is an IgG1 monoclonal antibody targeting CEACAM5 and is the naked antibody for Tusamitamab ravtansine. =

  • Mogroside III

    Mogroside III is a triterpenoid glycoside and a nonsugar sweetener. Mogroside III is transformed by human intestinal bacteria to release secondary glycoside mogroside IIA1 and aglycone mogrol.